D
Olema Pharmaceuticals, Inc. OLMA
$3.06 -$0.12-3.77%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 4.47M 4.40M 4.42M 4.46M 5.54M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 36.77M 37.62M 33.53M 34.34M 33.22M
Operating Income -36.77M -37.62M -33.53M -34.34M -33.22M
Income Before Tax -33.57M -34.56M -30.38M -30.97M -26.77M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -33.57M -34.56M -30.38M -30.97M -26.77M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -33.57M -34.56M -30.38M -30.97M -26.77M
EBIT -36.77M -37.62M -33.53M -34.34M -33.22M
EBITDA -36.65M -37.53M -33.44M -34.25M -33.13M
EPS Basic -0.51 -0.60 -0.54 -0.56 -0.49
Normalized Basic EPS -0.32 -0.38 -0.34 -0.35 -0.34
EPS Diluted -0.51 -0.60 -0.54 -0.56 -0.49
Normalized Diluted EPS -0.32 -0.38 -0.34 -0.35 -0.34
Average Basic Shares Outstanding 65.79M 57.26M 56.28M 55.57M 54.78M
Average Diluted Shares Outstanding 65.79M 57.26M 56.28M 55.57M 54.78M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings